J Appl Biomed 12:301-308, 2014 | DOI: 10.1016/j.jab.2014.04.002
Diethyldithiocarbamate complexes with metals used as food supplements show different effects in cancer cells
- a Department of Cell Biology & Genetics, Palacky University, Olomouc, Czech Republic
- b Chemical Engineering Department, ISEL, Lisboa, Portugal
- c Centro de Química Estrutural, Complexo I, Instituto Superior Técnico, Technical University of Lisbon, Lisboa, Portugal
Diethyldithiocarbamate (ditiocarb), a metabolite of the old anti-alcoholic drug disulfiram (Antabuse), forms proteasome-inhibiting metal complexes with copper or zinc that suppress cancer cells both in vitro and in vivo. The drug has been used in a clinical trial (NCT00742911) along with copper gluconate as a dietary supplement in patients with cancer spreading to the liver. In this study, we demonstrate the effect of synthetic complexes of disulfiram with four various metals (Mn, Fe, Cr and Cu) used as food supplements. These complexes may be spontaneously formed in the blood during the use of disulfiram with divalent metals and thus may suppress the growth of cancer in vivo. The cytotoxic effect of the compounds and the compounds' ability to inhibit the cellular proteasome were tested in the osteosarcoma cell line U2OS. After 48 h, copper and manganese complexes exhibited cytotoxic effect on the cell line, in sharp contrast to both iron and chromium complexes.
Keywords: Disulfiram; Dietary supplements; Dithiocarbamate-metal complexes; Cancer; Proteasome; Copper; Manganese
Received: April 14, 2014; Accepted: April 16, 2014; Published: November 1, 2014 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Adams, J., 2004. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5, 417-421.
Go to original source...
Go to PubMed...
- Almeida, S.S.P., Duarte, M.T., Ribeiro, L.M.D., Gormley, F., Galvão, A.M., Fraústo da Silva, J.J.R., Pombeiro, A.J.L., 1996. Formation of vinyl and dithioformate metallacycles by insertion of an ester functionalized alkyne or of carbon disulfide into an Fe-H bond: crystal structure of cis-[Fe (CH = CHCOOMe)(Ph2PCH2CH2PPh2)2][BF4]. J. Organomet. Chem. 524, 63-66.
Go to original source...
- Bedford, L., Paine, S., Sheppard, P.W., Mayer, R.J., 2010. Assembly, structure, and function of the 26S proteasome. J. Roelofs. Trends Cell Biol. 20, 391-401.
Go to original source...
Go to PubMed...
- Bell, R.L., Franklin, K.M., Hauser, S.R., Zhou, F.C., 2012. Introduction to the special issue ''Pharmacotherapies for the treatment of alcohol abuse and dependence'' and a summary of patents targeting other neurotransmitter systems. Recent Pat. CNS Drug Discov. 7, 93-112.
Go to original source...
Go to PubMed...
- Boguski, M.S., Mandl, K.D., Sukhatme, V.P., 2009. Drug discovery. Repurposing with a difference. Science 324, 1394-1395.
Go to original source...
Go to PubMed...
- Børup, C., Kaiser, A., Jensen, E., 1992. Long-term Antabuse treatment: tolerance and reasons for withdrawal. Acta Psychiatr. Scand. Suppl. 369, 47-49.
Go to original source...
Go to PubMed...
- Brar, S.S., Grigg, C., Wilson, K.S., Holder, W.D., Dreau, D., Austin, C., Foster, M., Ghio, A.J., Whorton, A.R., Stowell, G.W., Whittall, L.B., Whittle, R.R., White, D.P., Kennedy, T.P., 2004. Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol. Cancer Ther. 3, 1049-1060.
Go to original source...
- Cen, D., Gonzales, R.I., Buckmeier, J.A., Kahlon, R.S., Tohidian, N. B., Meyskens, F.L., 2002. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol. Cancer Ther. 1, 197-204.
- Chabner, B.A., Roberts, T.G., 2005. Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 5, 65-72.
Go to original source...
Go to PubMed...
- Chen, D., Peng, F., Cui, Q.C., Daniel, K.G., Orlu, S., Liu, J., Dou, Q. P., 2005. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Front. Biosci. 10, 2932-2939.
Go to original source...
Go to PubMed...
- Chen, D., Cui, Q.C., Yang, H., Dou, P.Q., 2006. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 21, 10425-10433.
Go to original source...
Go to PubMed...
- Chong, C.R., Sullivan, D.J., 2007. New uses for old drugs. Nature 448, 645-646.
Go to original source...
Go to PubMed...
- Chou, A.P., Maidment, N., Klintenberg, R., Casida, J.E., Li, S., Fitzmaurice, A.G., Fernagut, O., Mortazavi, F., Chesselet, M.F., Bronstein, J.M., 2008. Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. J. Biol. Chem. 283, 34696-34703.
Go to original source...
Go to PubMed...
- Cvek, B., 2011. Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome. Curr. Cancer Drug Targets 11, 1-6.
Go to original source...
Go to PubMed...
- Cvek, B., 2012a. Proteasome inhibitors. Prog. Mol. Biol. Transl. Sci. 109, 161-226.
Go to original source...
Go to PubMed...
- Cvek, B., 2012b. Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram). Drug Discov. Today 17, 409-412.
Go to original source...
Go to PubMed...
- Cvek, B., Dvorak, Z., 2007. Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals. Curr. Pharm. Des. 13, 3155-3167.
Go to original source...
Go to PubMed...
- Cvek, B., Dvorak, Z., 2008. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov. Today 13, 316-722.
Go to original source...
Go to PubMed...
- Cvek, B., Dvorak, Z., 2011. The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib. Curr. Pharm. Des. 17, 1483-1499.
Go to original source...
Go to PubMed...
- Cvek, B., Milacic, V., Tabara, J., Dou, P.Q., 2008. Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J. Med. Chem. 51, 6256-6258.
Go to original source...
Go to PubMed...
- Drexler, H.C., Risau, W., Konerding, M.A., 2000. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 14, 65-77.
Go to original source...
Go to PubMed...
- Dufour, P., Lang, J.M., Giron, C., Duclos, B., Haehnel, P., Jaeck, D., Jung, J.M., Oberling, F., 1993. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy 6, 9-12.
Go to original source...
Go to PubMed...
- Duriez, P.J., Snah, G.M., 1997. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol. 75, 337-349.
Go to original source...
Go to PubMed...
- Finley, D., 2009. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513.
Go to original source...
Go to PubMed...
- Fojo, T., Grady, C., 2009. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J. Natl. Cancer Inst. 101, 1044-1048.
Go to original source...
Go to PubMed...
- Gill, J., Ahluwalia, M.K., Geller, D., Gorlick, R., 2013. New targets and approaches in osteosarcoma. Pharmacol. Ther. 137, 89-99.
Go to original source...
Go to PubMed...
- Guo, X., Xu, B., Pandey, S., Goessl, E., Brown, J., Armesilla, A.L., Darling, J.L., Wang, W., 2010. Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett. 290, 104-113.
Go to original source...
Go to PubMed...
- Healy, P.C., White, A.H., 1972a. Crystal structure of tris-(NN- diethyldithiocarbamato)manganese(III). J. Chem. Soc. Dalton Trans. 1, 1883-1887.
Go to original source...
- Healy, P.C., White, A.H., 1972b. Structural studies in the tris(NN- dialkyldithiocarbamato)iron(III) 'cross-over' system. J. Chem. Soc. Dalton Trans. 1163-1171.
Go to original source...
- Hogarth, G., 2005. Transition metal dithiocarbamates: 1978- 2003. Prog. Inorg. Chem. 53, 71-561.
Go to original source...
- Hogarth, G., 2012. Metal-dithiocarbamate complexes: chemistry and biological activity. Mini-Rev. Med. Chem. 12, 1202-1215.
Go to original source...
Go to PubMed...
- Johansson, B., 1992. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr. Scand. Suppl. 369, 15-26.
Go to original source...
Go to PubMed...
- Kortuem, K.M., Stewart, A.K., 2013. Carfilzomib. Blood 121, 893-897.
Go to original source...
Go to PubMed...
- Kwolek-Mirek, M., Zadrag-Tercza, R., Bartosz, G., 2012. Ascorbate and thiol antioxidants abolish sensitivity of yeast Saccharomyces cerevisiae to disulfiram. Cell Biol. Toxicol. 28, 1-9.
Go to original source...
Go to PubMed...
- Lewison, E.F., 1977. Spontaneous regression of breast cancer. Prog. Clin. Biol. Res. 12, 47-53.
- Liu, P., Brown, S., Goktug, T., Channathodiyil, P., Kannappan, V., Hugnot, J.P., Guichet, P.O., Bian, X., Armesilla, A.L., Darling, J. L., Wang, W., 2012. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer- stem-like cells. Br. J. Cancer 107, 1488-1497.
Go to original source...
Go to PubMed...
- Martínez-Fríaz, M.L., 2012. The thalidomide experience: review of its effects 50 years later. Med. Clin. (Barc.) 139, 25-32.
Go to original source...
Go to PubMed...
- Morrison, B.W., Doudican, N.A., Patel, K.R., Orlow, S.J., 2010. Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Melanoma Res. 20, 11-20.
Go to original source...
Go to PubMed...
- Nieuwenhuizen, P.J., Reedijk, J., van Duin, M., McGill, J.W., 1997. Thiuram- and dithiocarbamate-accelerated sulfur vulcanization from the chemist's perspective; methods, materials and mechanisms reviewed. Rubber Chem. Technol. 70, 368-429.
Go to original source...
- O'Brian, A., Barber, J.E., Reid, S., Niknejad, N., Dimitroulakos, J., 2012. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3. Anticancer Res. 7, 2679-2688.
- Rae, C., Tesson, M., Babich, J.W., Boyd, M., Sorensen, A., Mairs, R., 2013. The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. J. Nucl. Med. 56, 953-960.
Go to original source...
Go to PubMed...
- Skrott, Z., Cvek, B., 2012. Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells. Mini-Rev. Med. Chem. 12, 1184-1192.
Go to original source...
Go to PubMed...
- Suh, J.J., Pettinati, M.H., Kampman, K.M., O'Brian, C.P., 2006. The status of disulfiram: a half of a century later. J. Clin. Psychopharmacol. 26, 290-302.
Go to original source...
Go to PubMed...
- Sunderman, F.W., Schneider, H.P., Lumb, G., 1984. Sodium diethyldithiocarbamate administration in nickel-induced malignant tumors. Annu. Clin. Lab. Sci. 14, 1-9.
- Ta, H.T., Dass, C.R., Choon, P.F., Dunstan, D.E., 2009. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 28, 247-263.
Go to original source...
Go to PubMed...
- Thorn, G.D., Ludwig, R.A., 1962. The Dithiocarbamates and Related Compounds. Elsevier Publishing Co, Amsterdam.
- Vaux, D.L., Strasser, A., 1996. The molecular biology of apoptosis. PNAS 93, 2239-2244.
Go to original source...
Go to PubMed...
- Vera-Badillo, F.E., Al-Mubarak, M., Templeton, A.J., Amir, E., 2013. Benefit and harms of new anti-cancer drugs. Curr. Oncol. Rep. 15, 270-275.
Go to original source...
Go to PubMed...
- Verani, C.N., 2012. Metal complexes as inhibitors of the 26S proteasome in tumor cells. J. Inorg. Biochem. 106, 59-67.
Go to original source...
Go to PubMed...
- Viola-Rhenals, M., Riebr, M.S., Riebr, M., 2006. Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate. Biochem. Pharmacol. 14, 722-734.
Go to original source...
Go to PubMed...
- Wattenberg, L.W., 1975. Inhibition of dimethylhydrazine- induced neoplasia of the large intestine by disulfiram. J. Natl. Cancer Inst. 54, 1005-1006.
Go to original source...
Go to PubMed...
- Wong, T., 2012. Parenteral trace elements in children: clinical aspects and dosage recommendations. Curr. Opin. Clin. Nutr. Metab. Care 15, 649-656.
Go to original source...
Go to PubMed...
- Xu, B., Shi, P., Fombon, I.S., Zhang, Y., Huang, F., Wang, W., Zhou, S., 2011. Disulfiram/copper complex activated JNK/c- jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells. Blood Cells Mol. Dis. 4, 264-269.
Go to original source...
Go to PubMed...
- Yu, Z., Wang, F., Milacic, V., Li, X., Cui, Q.C., Zhang, B., Yan, B., Dou, Q.P., 2007. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues. Int. J. Mol. Med. 20, 919-925.
Go to original source...
Go to PubMed...